{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:16:13Z","timestamp":1780492573353,"version":"3.54.1"},"reference-count":15,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1179\/joc.2009.21.4.434","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T13:06:00Z","timestamp":1389272760000},"page":"434-438","source":"Crossref","is-referenced-by-count":3,"title":["Accelerated R-COP: A Pilot Study for the Treatment of Advanced Low Grade Lymphomas that Has a High Complete Response Rate"],"prefix":"10.1080","volume":"21","author":[{"given":"M.J.","family":"Levitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gharibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Strair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508"},{"issue":"5","key":"CIT0003","first-page":"1504","volume":"108","author":"Buske C","year":"2006","journal-title":"The Follicular Lymphoma International Prog-nostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophos-phamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802311391"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3175"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi264"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.137"},{"key":"CIT0009","unstructured":"http:\/\/ctep.cancengov\/protocolDevelopment\/elec-tronic applications\/ctc.htn"},{"key":"CIT0010","unstructured":"Garcia-Conde J, Conde E, Sierra J, Caballero D, Arranz R, Leon A, et al. Rituximab (IDEC-C2B8) and CVP chemother-apy in follicular of low grade b-cell lymphoma after relapse: results after 6 months of follow-up. Proc Am Soc Clin Oncol, 2000. 19: p. (abstr 96)."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.068"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0023-2"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.7952"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154642.45474.28"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.004"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10894"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021113"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T07:16:29Z","timestamp":1481699789000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2009.21.4.434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1179\/joc.2009.21.4.434"],"URL":"https:\/\/doi.org\/10.1179\/joc.2009.21.4.434","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}